HAZLET, N.J. - June 30, 2026 - PRLog -- Historically, ATTR-CM was considered a rare disease; however, it is now recognized as a more common cause of heart failure (HF) than previously thought. Despite recent attention to ATTR-CM, the condition is significantly underdiagnosed. Timely diagnosis is crucial, as it has the potential to reduce mortality and HF hospitalization when treated with targeted therapies. In this symposium, ATTRCM experts (symposium chair Dr. Mathew Maurer, faculty members Dr. Jan Griffin and Dr. Frederick Ruberg), will provide attendees with best practices for evaluating, diagnosing, and treating patients with ATTR-CM.
Click here for more information
CHAIR
Mathew Maurer, MD
Arnold and Arlene Goldstein Professor of Cardiology
Professor of Medicine
Columbia University Irving Medical Center
Vagelos College of Physicians & Surgeons
New York, New York
FACULTY
Jan Griffin, MD
Associate Professor of Medicine
Medical University of South Carolina
Charleston, South Carolina
Frederick Ruberg, MD
Thomas J. Ryan Professor of Cardiovascular Medicine
Chief, Cardiovascular Medicine
Professor of Radiology
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center
Boston, Massachusetts
Educational Objectives
- Recognize the cardiac and extracardiac red flags which raise suspicion for ATTR-CM.
- Describe the diagnostic testing components to quickly and accurately diagnose ATTR-CM.
- Summarize current recommendations for use of HF GDMT in ATTR-CM patients and the evolving evidence for Silencers and Stabilizers for ATTR-CM.
- Identify the recommended parameters for monitoring disease progression in ATTR-CM.
Target Audience
This program is intended for clinicians who manage patients with heart failure.
Educational Grant
Voxmedia gratefully acknowledges the independent educational grant provided by Alnylam Pharmaceuticals, Inc. and BridgeBio.
Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia, LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Photos: (Click photo to enlarge)
Source: CMEPlanet
Read Full Story - 2026 HFM CME Symposium - Overcoming Challenges in Transthyretin Cardiac Amyloidosis | More news from this source
Press release distribution by PRLog
